Nov 4, 2024 · Legend Biotech is a global, commercial-stage biotechnology company developing and manufacturing novel therapies. We explore and apply innovative technologies to deliver cutting-edge options for patients around the world.

Legend Biotech is a global, commercial-stage biotechnology company developing, manufacturing and commercializing novel therapies. We explore and apply innovative technologies to deliver cutting-edge options for patients around the world.

Legend Biotech was founded as an early-stage cell therapy company in 2014. The company was the brainchild of visionary scientists who recognized that antibody-based therapeutics could potentially treat disease and possessed the backgrounds in immunology and …

At Legend Biotech, we are a team of experts committed to quality, driven by excellence, and dedicated to experimentation. Together, we are transforming the world of oncology and medicine. Open Roles

Therapies. We endeavor to deliver innovative options to patients and healthcare providers through tireless exploration and discovery. We are just getting started.

Pipeline. Our pipeline is made up of investigative therapies and innovative technologies in personalized medicine. We are devoted to exploring the potential of cell therapies to treat diseases that are considered intractable and incurable, such as …

Legend is developing cell therapies that aim to help strengthen patients’ immune systems to fight disease. We explore several innovative and evolving technologies to treat blood and solid cancers: autologous chimeric antigen receptor T-cell therapy (CAR-T); and allogeneic CAR-T, natural killer (NK) cells and gamma-delta (γδ) T cells.

Legend Biotech is currently discovering and developing a broad portfolio of cell therapies to help strengthen patients’ immune systems and fight disease. We explore several innovative and evolving technologies to treat hematologic malignancies and solid tumors: autologous chimeric antigen receptor T-cell therapy (CAR-T), allogeneic non-gene ...

Be aware that certain names, logos, and slogans are trademarks, even if not specifically mentioned. Without limitation, LEGEND BIOTECH, the stylized Legend Biotech typeface logo, and the stylized modern-helix LB logo are trademarks of Legend Biotech USA Inc. …

Nov 13, 2023 · The deal with Novartis seeks to advance Legend Biotech’s autologous CAR-T cell therapy candidate, LB2102, and other potential CAR-T cell therapies targeting Delta-like ligand protein 3 (DLL3), using the Novartis next-generation T-Charge™ CAR-T cell therapy platform